HCM (HUTCHMED (China) Limited American Depositary Shares) Stock Analysis - AI Report

HUTCHMED (China) Limited American Depositary Shares (HCM) is a publicly traded Healthcare sector company. As of May 21, 2026, HCM trades at $11.95 with a market cap of $2.05B and a P/E ratio of 0.00. HCM moved +0.00% today. Year to date, HCM is -10.92%; over the trailing twelve months it is -10.25%. Its 52-week range spans $11.51 to $21.50. Analyst consensus is buy with an average price target of $20.00. Rallies surfaces HCM's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What is the AI research view on HCM?

Rallies AI research for HCM combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.

HCM Key Metrics

Key financial metrics for HCM
MetricValue
Price$11.95
Market Cap$2.05B
P/E Ratio0.00
EPS$0.00
Dividend Yield0.00%
52-Week High$21.50
52-Week Low$11.51
Volume22
Avg Volume0
Revenue (TTM)$0
Net Income$0
Gross Margin0.00%

Latest HCM News

HCM Analyst Consensus

1 analysts cover HCM: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $20.00.

Common questions about HCM

What is the AI research view on HCM?
Rallies AI research for HCM combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
What data powers the Rallies AI report for HCM?
Rallies AI research for HCM combines live market data, financials, news, analyst context, hedge fund ownership, politician disclosures, insider activity, and risk factors.
Is HCM research on Rallies investment advice?
No. Rallies provides research, data, and educational context for HCM. It does not provide personalized investment advice.
HCM

HCM